Search

Displaying results 6251 - 6260 of 8171 in total
  1. Drug

    Atrasentan

    go.drugbank.com/drugs/DB06199
    ApprovedInvestigational

    Atrasentan is a novel, selective endothelin A receptor antagonist (SERA). In April 2025, atrasentan was granted accelerated approval by the FDA for the reduction of proteinuria in patients with primary IgA nephropathy, becoming the first...

    Categories: Cytochrome P-450 CYP2B6 Inducers, P-glycoprotein inhibitors
  2. Drug

    Human umbilical cord blood mononuclear cell-conditioned medium

    go.drugbank.com/drugs/DB15724
    Experimental

    Transplantation with human umbilical cord blood mononuclear cells (HUCBC) has demonstrated promising results in various disease states. While some of the positive results are credited to HUCBCs’ differentiation potential, the growth fact...

  3. Drug

    Zoloperone

    go.drugbank.com/drugs/DB19862
    Experimental

    Zoloperone has a monoisotopic molecular weight of 397.18 Da.

  4. Drug

    Cloroperone

    go.drugbank.com/drugs/DB20384
    Experimental

    Cloroperone has a monoisotopic molecular weight of 387.14 Da.

  5. Drug

    Bromchlorenone

    go.drugbank.com/drugs/DB20459
    Experimental

    Bromchlorenone has a monoisotopic molecular weight of 246.9 Da.

  6. Drug

    Ambamustine

    go.drugbank.com/drugs/DB20805
    Experimental

    Ambamustine has a monoisotopic molecular weight of 628.21 Da.

  7. Drug

    Spiromustine

    go.drugbank.com/drugs/DB20825
    Experimental

    Spiromustine has a monoisotopic molecular weight of 335.12 Da.

  8. Drug

    Stirocainide

    go.drugbank.com/drugs/DB20924
    Experimental

    Stirocainide has a monoisotopic molecular weight of 342.27 Da.

  9. Drug

    Roxoperone

    go.drugbank.com/drugs/DB20046
    Experimental

    Roxoperone has a monoisotopic molecular weight of 346.17 Da.

  10. Drug

    Pincainide

    go.drugbank.com/drugs/DB20097
    Experimental

    Pincainide has a monoisotopic molecular weight of 260.19 Da.